Write an article on Subject Response in Biology, It needs to be at least 1250 words

Write an article on Subject Response in Biology, It needs to be at least 1250 words. In BTA, patients’ blood, urine, and saliva specimens are analyzed using a computer to detect evidence of disease at cellular level such as the risk of malignant processes. In line with this, electron levels, pH balance, and minerals in blood, saliva, and urine are measured (Becchetti & Kessler, 1999). However, Barrett (2002) wrote an article claiming that this method is not effective in terms of diagnosing nor select inappropriate treatment for cancer.

CBC blood test checks on the indicators of cancer cells in 44 substances that are commonly found in the blood whereas darkfield microscopy enables doctors to view healthy and unhealthy blood cells. However, additional laboratory tests like DR-70 are required to verify the results of darkfield microscopy test. DR-70 is a simple blood test that screens for 13 different cancer cells in lungs, colon, breast, liver, rectum, ovary, stomach, cervix, esophagus, thyroid, pancreas, malignant lymphoma, and trophoblast

Cancer Marker Test is an immunological method used in detecting cancer cell markets. Specifically, this method is used for the early detection of cancer cells. Tumor markers used in detecting cancer cells includes Alpha-fetoprotein (AFP), CA 15.3, CA 19.9, CA 125, Carcinoembryonic antigen (CEA), and EVP (The Cancer Cure Foundation, 2010).

Although the levels of alpha-fetoprotein (AFP) among pregnant women, it is normal for cancer patients to have elevated levels of alpha-fetoprotein (AFP) especially in case of liver, gastrointestinal, and testicular cancers (Yachida et al., 2003). It is also common for cancer patients to have an elevated CA 15.3 particularly among those individuals with breast cancer (Vizcarra et al., 1996). In case a person has a history of breast cancer, patients can be advised to have regular breast mammogram. Cancer market test on CA 15.3 can be used in case doctors suspect that a patient has a breast cancer.